Effect of Postablation Monitoring Strategy on Long-Term Outcome for Catheter Ablation of Persistent Atrial Fibrillation: A Substudy of the STAR AF II Trial

Affiliations

• ¹ Southlake Regional Health Centre, Newmarket, Canada (S.C., A.V.).
• ² University of Tor Vergata, Rome, Italy (S.C.).
• ³ Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China (C.-y.J.).
• ⁴ Department of Cardiology, Oxford University Hospitals, John Radcliffe Hospital, United Kingdom (T.R.B.).
• ⁵ Haukeland University Hospital, University of Bergen, Norway (J.C.).
• ⁶ Deutsches Herzzentrum München, Munich, Germany (I.D.).
• ⁷ Ospedale S. Maria di Ca' Foncelli, Treviso, Italy (R.M.).
• ⁸ Montreal Heart Institute, Canada (L.M.).
• ⁹ Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Canada (C.A.M.).
• ¹⁰ Department of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany (W.H.).
• ¹¹ Department of Cardiology, Hollywood Private Hospital, Nedlands, Western Australia (R.W.).
• ¹² Department of Cardiology, University of Western Australia, Crawley (R.W.).
• ¹³ Département de Rythmologie, Clinique Pasteur Toulouse, France (J.-P.A.).
• ¹⁴ Pineta Grande Hospital, Castel Volturno, Italy (S.N.).
• ¹⁵ Ospedale Santa Croce e Carle, Cuneo, Italy (E.M.).
• ¹⁶ Royal Jubilee Hospital, Victoria, Canada (P.N.).
• ¹⁷ Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital, Australia (P.S.).
• ¹⁸ Department of Surgery, University of Toronto, Canada (A.V.).